These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 170878)

  • 1. [Hypophyseal gonadotropin secretion in sexual precocity with McCune-Albright's syndrome].
    Lecointre C; Chaussain JL; Vassai J; Job JC
    Arch Fr Pediatr; 1975; 32(6):533-9. PubMed ID: 170878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. McCune-Albright syndrome with sexual precocity in a boy.
    Nitzan M; Laron Z; Pertzelan A; Scharf A
    Helv Paediatr Acta; 1973 Mar; 28(1):61-5. PubMed ID: 4696146
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyostotic fibrous dysplasia with raised steroid excretion.
    Alexander FW
    Arch Dis Child; 1971 Feb; 46(245):91-4. PubMed ID: 5555493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testolactone treatment of precocious puberty in McCune-Albright syndrome.
    Foster CM; Pescovitz OH; Comite F; Feuillan P; Shawker T; Loriaux DL; Cutler GB
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):254-7. PubMed ID: 3925675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual precocity associated with a hypothalamic tumour. Effects of sex hormone therapy.
    David R; Rawlinson J; Ferguson KM
    Arch Dis Child; 1975 Feb; 50(2):157-60. PubMed ID: 165785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of Albright's syndrome.
    Ikari Y; Misonwo T; Nishibori M; Sasaki T; Katagiri T
    Nihon Seikeigeka Gakkai Zasshi; 1966 Nov; 40(8):1139-43. PubMed ID: 6009877
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function.
    Lightner ES; Penny R; Frasier SD
    J Pediatr; 1975 Dec; 87(6 Pt 1):922-7. PubMed ID: 1185394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albright's syndrome with rickets.
    McArthur RG; Hayles AB; Lambert PW
    Mayo Clin Proc; 1979 May; 54(5):313-20. PubMed ID: 431133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medroxyprogesterone acetate in the treatment of idiopathic precocious puberty].
    Severi F; Burgio GR
    Padiatr Padol; 1972; 7(3):297-304. PubMed ID: 4341412
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic isosexual precocity.
    Kaplan SA; Ling SM; Irani NG
    Am J Dis Child; 1968 Dec; 116(6):591-8. PubMed ID: 5697190
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of Albright's syndrome].
    Pilak M; Mraz F
    Czas Stomatol; 1978 Aug; 31(8):763-7. PubMed ID: 278727
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
    Foster CM; Ross JL; Shawker T; Pescovitz OH; Loriaux DL; Cutler GB; Comite F
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1161-5. PubMed ID: 6427261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersecretion of hypothalamic releasing hormones: a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's syndrome).
    Hall R; Warrick C
    Lancet; 1972 Jun; 1(7764):1313-6. PubMed ID: 4113403
    [No Abstract]   [Full Text] [Related]  

  • 16. Sexual precocity.
    McDonough PG
    Clin Obstet Gynecol; 1971 Dec; 14(4):1037-56. PubMed ID: 4259875
    [No Abstract]   [Full Text] [Related]  

  • 17. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.
    Reiter EO; Kaplan SL; Conte FA; Grumbach MM
    Pediatr Res; 1975 Feb; 9(2):111-6. PubMed ID: 1090891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen production in boys with sexual precocity and congenital adrenal hyperplasia.
    Levine LS; New MI; Pitt P; Peterson RE
    Metabolism; 1972 May; 21(5):457-64. PubMed ID: 4335735
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of synthetic luteinizing hormone-releasing hormone (LH-RH) on the release of gonadotropins in hypophyso-gonadal disorders of children and adolescents. II. Precocious puberty and premature thelarche.
    Job JC; Garnier PE; Chaussain JL; Canlorbe P
    Biomedicine; 1973 Feb; 19(2):77-81. PubMed ID: 4581504
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.